Background: To study how metabolic control at onset of type 1 diabetes correlates to metabolic control and clinical parameters during childhood until transition from pediatric care to adult diabetes care.
| INTRODUCTION
Type 1 diabetes mellitus (T1D) is the second most common chronic disease in children and adolescents. Intensive therapy of patients with T1D delays the onset of long-term complications and slows the progression of complications. [1] [2] [3] [4] Intensive treatment improves metabolic control, measured as HbA1c (glycated hemoglobin), which reflects the mean glycaemic level during the preceding 2 to 3 months. 5 Frequent self-monitoring of blood glucose (SMBG) is also important in order to improve metabolic control and reduce the risk of both short-term complications (ie hypoglycemic events and ketoacidosis) and long-term vascular complications. 6 Metabolic control close to diagnosis of the disease has been shown to be related to later metabolic control. [7] [8] [9] [10] Viswanathan et al showed that HbA1c levels at onset might predict future metabolic control; however, the study only included 120 children with data obtained at diagnosis and at follow-up after 6 weeks, 1, 2, 3, and 4 years after diagnosis and was conducted with data from a large tertiary care center. 11 Redondo et al studied determinants of HbA1c one year after diagnosis of T1D, in 857 patients recruited from 7 clinical centers, and found no association of HbA1c at onset and HbA1c value 1 year after diagnosis. 12 It has recently been shown that a high mean HbA1c shortly after diagnosis (ie 3-15 months after onset) and during adolescence increases the risk for microvascular complications in early adulthood. 13, 14 Hofer et al described metabolic tracking from childhood until young adulthood, identifying prepubertal HbA1c as a predictor of metabolic control in young adulthood, but the influence of HbA1c at onset per se was not studied. 15 Lind et al have shown an excess risk of death from any cause for adult Swedish patients with T1D; a doubled risk even with good glycaemic control, ≤ 52 mmol/mol (6.9%), and an almost 10 times higher mortality risk with a mean HbA1c above 83 mmol/mol (9.7%). Adults ≤ 34 years of age had an increased risk of premature death, and diabetic ketoacidosis and hypoglycemia contributed to 31.4% of this risk. 16 It is not known how these individuals presented at onset and how their metabolic control was during childhood.
Increasing evidence indicates the importance of good glycaemic control during childhood, to avoid future morbidity and premature death. However, the importance of HbA1c at disease onset is not well studied. Present studies either include few patients or have short follow-up time and none is based on nationwide data. 
| Study population
All children and adolescents diagnosed with T1D and registered in SWEDIABKIDS 2000 to 2014 were included, which renders the study population nationwide and population-based. Visits where HbA1c was not registered were not included in the analysis. 8084
patients that had an HbA1c value registered at the one-year followup after diagnosis were included, and of these, 26% had been transitioned to adult care in 2014.
Data was obtained at onset, 3 months, 1, 3, and 5 years after diagnosis and at transition. HbA1c, BMI, BMI SDS, blood pressure, pH-value at diagnosis, physical activity, smoking, gender and retinopathy were recorded. Smoking was analyzed in children 13 years of age or older and physical activity in children seven years of age or older, as these data are not registered in younger children in SWE-DIABKIDS. Smoking and physical activity are not registered until the 3-month follow-up after diagnosis. Retinopathy is assessed locally, that is, through fundus photography performed by an ophthalmologist, and categorized as yes or no.
HbA1c at onset was divided into quintiles, the lowest with HbA1c < 72 mmol/mol (8.7%) (low group) and the highest with HbA1c > 114 mmol/mol (12.6%) (high group). The quintiles 2 to 4 were defined as moderate group, HbA1c 72 to 114 mmol/mol (8.7-12.6%). These groups were thereafter compared with mean HbA1c at follow-up and with clinical parameters both at onset and follow-up.
| Statistical analysis
SPSS 22 (SPSS Inc., Chicago, Illinois) was used for the analyses. The statistical methods were descriptive. A student's t-test and one-way analysis of variance (ANOVA) was used, including the Bonferroni procedure. Groups were compared by crosstabs, and chi-square was used for proportions. Linear regression was used to test the relationship between HbA1c at diagnosis and at follow-up. A P value < .05, two-sided was regarded as statistically significant. Results are presented as mean AE SD.
The study was approved by the regional ethics committee in Linköping, Sweden.
| RESULTS
Background data on number of patients included and HbA1c values at each follow-up time are shown in Table 1 .
Patients in the low HbA1c group at diagnosis were younger (P < .001), had higher BMI SDS (P < .01), lower blood pressure (P < .01) and higher pH-value (P < .01) compared to the high HbA1c group. The proportion of girls was higher in the high group (Table 2 ).
This was not an effect of age at diagnosis, as girls had a mean age of 8.9 AE 4.1 vs boys 9.6 AE 4.7 years (P < .001).
Children and adolescents in the high HbA1c group at diagnosis were more frequently smokers (P < .01), were less physically active (P < .01), had higher BMI SDS (P < .01), higher blood pressure (P < .05), and higher frequency of retinopathy (P < 0.03) at follow-up after five years than children in the low HbA1c group at diagnosis (Table 2, Figure 1 ). For smokers at the 5-year follow-up, HbA1c was 79 AE 17 mmol/mol (9.4 AE 1.6%) vs 63 AE 13 mmol/mol (7.9 AE 1.2%)
for non-smokers (n = 1702, P < .001). For children with retinopathy, after five years HbA1c was 71 AE 16 mmol/mol (8.6 AE 1.5%) vs 64 AE 13 mmol/mol (8.0 AE 1.2%) for those without retinopathy (n = 369, P < .01). Children with ketoacidosis at disease onset (pH < 7.30) had marginally higher HbA1c at follow-up vs children with normal pH at onset, mean 64 mmol/mol (8.0%) at the 5-year follow-up vs 63 mmol/mol (7.9%) (P = 0.096), and 69 mmol/mol (8.5%) at transition vs 67 mmol/mol (8.3%) (P = .023).
Girls were overrepresented in the high HbA1c group at onset.
23.5% of the girls and 16.6% of the boys had HbA1c >114 mmol/mol (12.6%) at diagnosis (P < .001). In the low HbA1c group at diagnosis, the distribution was 18.1% girls and 20.3% boys and in the moderate HbA1c group (quintile 2-4) 58.4% girls and 63.1% boys (P < 0.001).
Girls had marginally higher HbA1c during follow-up except after 3 years. The difference was not significant except at transition, where Children in the low group at diagnosis, HbA1c < 72 mmol/mol (8.7%), had better metabolic control during childhood and adolescence, compared to children in the high group at diagnosis, HbA1c > 114 mmol/mol (12.6%). The difference was significant at every follow-up point except at transition (3 months P < .05, one year P < .05, 3 years P < .01, 5 years P < .01, at transition n.s.). In general,
HbA1c increases during follow-up ( Figure 2 ).
When using a linear regression model, there was no predictive value between HbA1c at onset and future metabolic control for the individual (R 2 = 0.022 at five-year follow-up, Figure 3 ).
| DISCUSSION
This nationwide population-based study shows that HbA1c at diagnosis affects future metabolic control during childhood and adolescence. This confirms earlier studies by Viswanathan et al 11 and
Shalitin and Phillip, 10 which both had small numbers of patients and short follow-up times.
One explanation might be that families who are unaware of their children's symptoms at diagnosis are also less aware of symptoms of poor metabolic control later. The clinical difference in HbA1c is not marked at the 3-month follow-up, which could be explained by residual beta-cell function during the first months, which then subsides and gives more pronounced differences at 3-year and 5-year followups. The difference in HbA1c at transition is not significant. These patients are older and may receive more input from the diabetes team and may participate more actively in their care. Girls had higher levels of HbA1c than boys, both at diagnosis and follow-up, which has already been shown by Åkesson et al.. 21 It was there shown that higher HbA1c at diagnosis was correlated to a decrease in BMI and pH, thereby presenting with more disease symptoms. The reason for this is not understood. Could there be less awareness of disease symptoms in girls than in boys at onset? The reason might also be due to the well-known hormonal differences between genders.
Children presenting with high HbA1c were older than those with low HbA1c at onset -mean age 12.6 years compared to mean age 7.6 years. The patients with high HbA1c at diagnosis continued to have poor metabolic control as a group. This is in line with a study by Clements et al., where older age at diagnosis was a predictor for deterioration in glycemic control during the first five years after diagnosis, and they also presented with higher HbA1c values. 22 This could be due to hormone-induced insulin resistance during puberty. 23, 24 In contrast to younger children, teenagers are often more actively involved in their own treatment and may be expected to take more responsibility for their disease. It may be difficult to establish good metabolic control later during the course of disease if tight metabolic control is not achieved close to diagnosis, and adolescence is known as a problematic period when it comes to adherence to treatment and achieving glycemic control. [25] [26] [27] Taking this into account, it is important but also a challenge for the diabetes team to encourage teenagers to improved self-care and a healthy lifestyle, that is, increased physical activity and non-smoking habits, as a way to decrease HbA1c levels in this age group.
Other explanations for why some children present with very high This is a large, population-based study with a retrospective design. The data is based on registry information and relies on correct information being entered into the registry.
In summary, this study shows that having high HbA1c at diagnosis is associated with poor metabolic control during childhood on a group level, thereby in part confirming previous smaller studies, but for the individual high HbA1c cannot be used as a predictor for future metabolic control. In other words, the work done by the diabetes team the first years after diagnosis, despite age at onset, truly makes a difference, and it is important to maintain this investment in team and patients in order to prevent continuously high HbA1c and diabetic complications.
Clinical characteristics such as older age and low BMI SDS at onset, smoking and low physical activity, together with female gender can be of help in identifying which patients the diabetes team needs to focus on and provide extra support to right from the start.
